UMN And Windgap Medical Receive $3.2 Million NIH Grant To Develop Cyanide Antidote Autoinjector
![Steve Patterson](/sites/drugdesign.umn.edu/files/2020-08/steve_patterson_690x350.png)
The University of Minnesota Twin Cities and Windgap Medical have received a $3.2 million grant from the National Institutes of Health (NIH) to develop a new device to quickly administer a recently developed antidote for cyanide poisoning.
Categories